Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody

被引:95
作者
Clemm, DL
Sherman, L
Boonyaratanakornkit, V
Schrader, WT
Weigel, NL
Edwards, DP
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Sch Med, Denver, CO 80262 USA
[2] Univ Colorado, Sch Med, Program Mol Biol, Denver, CO 80262 USA
[3] Ligand Pharmaceut Inc, Endocrine Res, San Diego, CA 92121 USA
[4] Baylor Coll Med, Dept Cellular & Mol Biol, Houston, TX 77030 USA
关键词
D O I
10.1210/me.14.1.52
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Human progesterone receptor (PR) is phosphorylated on multiple serine residues (at least seven sites) in a manner that involves distinct groups of sites coordinately regulated by hormone and different kinases. Progress on defining a functional role for PR phosphorylation has been hampered both by the complexity of phosphorylation and the lack of simple, nonradioactive methods to detect the influence of ligands and other signaling pathways on specific PR phosphorylation sites in vivo. Toward this end, we have produced monoclonal antibodies (MAbs) that recognize specific phosphorylation sites within human PR including a basal site at Set 190 (MAb P190) and a hormone-induced site at Ser 294 (MAb P294). Biochemical experiments showed the differential reactivity of the P190 and P294 MAbs for phosphorylated and unphosphorylated forms of PR. Both MAbs recognize specific phosphorylated forms of PR under different experimental conditions including denatured PR protein by Western blots and PR in its native conformation in solution or complexed to specific target DNA. As detected by Western blot of T47D cells treated with hormone for different times, hormone-dependent down-regulation of total PR and the Ser 190 phosphorylation site occurred in parallel, whereas the Ser 294 phosphorylation site was down-regulated more rapidly. This difference in kinetics suggests that the Ser 294 site is more labile than basal sites and is acted upon by distinct phosphatases. A strong preferential hormone-dependent phosphorylation of Ser 294 was observed on PR-B as compared with the aminoterminal truncated A form of PR. This was unexpected because Ser 294 and flanking sequences are identical on both proteins, suggesting that a distinct conformation of the N-terminal domain of PR-A inhibits phosphorylation of this site. That Ser 294 lies within an inhibitory domain that mediates the unique repressive functions of PR-A raises the possibility that differential phosphorylation of Ser 294 is involved in the distinct functional properties of PR-A and PR-B.
引用
收藏
页码:52 / 65
页数:14
相关论文
共 43 条
[1]
MODULATION OF TRANSCRIPTIONAL ACTIVATION BY LIGAND-DEPENDENT PHOSPHORYLATION OF THE HUMAN ESTROGEN RECEPTOR-A/B REGION [J].
ALI, S ;
METZGER, D ;
BORNERT, JM ;
CHAMBON, P .
EMBO JOURNAL, 1993, 12 (03) :1153-1160
[2]
Phosphorylation of Ser(211) in the chicken progesterone receptor modulates its transcriptional activity [J].
Bai, WL ;
Weigel, NL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12801-12806
[3]
PHOSPHORYLATION OF SER(530) FACILITATES HORMONE-DEPENDENT TRANSCRIPTIONAL ACTIVATION OF THE CHICKEN PROGESTERONE-RECEPTOR [J].
BAI, WL ;
TULLOS, S ;
WEIGEL, NL .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (11) :1465-1473
[4]
BAIN DL, 1999, 81 ANN M END SOC SAN, P187
[5]
Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor [J].
Beck, CA ;
Zhang, YX ;
Weigel, NL ;
Edwards, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1209-1217
[6]
EFFECTS OF HORMONE AND CELLULAR MODULATORS OF PROTEIN-PHOSPHORYLATION ON TRANSCRIPTIONAL ACTIVITY, DNA-BINDING, AND PHOSPHORYLATION OF HUMAN PROGESTERONE RECEPTORS [J].
BECK, CA ;
WEIGEL, NL ;
EDWARDS, DP .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (04) :607-620
[7]
Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system [J].
Beck, CA ;
Zhang, YX ;
Altmann, M ;
Weigel, NL ;
Edwards, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19546-19555
[8]
THE PROGESTERONE ANTAGONIST RU486 ACQUIRES AGONIST ACTIVITY UPON STIMULATION OF CAMP SIGNALING PATHWAYS [J].
BECK, CA ;
WEIGEL, NL ;
MOYER, ML ;
NORDEEN, SK ;
EDWARDS, DP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4441-4445
[9]
High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells [J].
Boonyaratanakornkit, V ;
Melvin, V ;
Prendergast, P ;
Altmann, M ;
Ronfani, L ;
Bianchi, ME ;
Taraseviciene, L ;
Nordeen, SK ;
Allegretto, EA ;
Edwards, DP .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (08) :4471-4487
[10]
PROTEIN PHOSPHATASE TYPES-1 AND OR 2A REGULATE NUCLEOCYTOPLASMIC SHUTTLING OF GLUCOCORTICOID RECEPTORS [J].
DEFRANCO, DB ;
QI, M ;
BORROR, KC ;
GARABEDIAN, MJ ;
BRAUTIGAN, DL .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (09) :1215-1228